PHAT logo

Phathom Pharmaceuticals, Inc. (PHAT) Net Income

Annual Net Income:

-$334.33M-$132.73M(-65.84%)
December 31, 2024

Summary

  • As of today, PHAT annual net profit is -$334.33 million, with the most recent change of -$132.73 million (-65.84%) on December 31, 2024.
  • During the last 3 years, PHAT annual net income has fallen by -$190.44 million (-132.36%).
  • PHAT annual net income is now -25856.99% below its all-time high of -$1.29 million, reached on December 31, 2018.

Performance

PHAT Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

Quarterly Net Income:

-$29.97M+$45.84M(+60.46%)
September 30, 2025

Summary

  • As of today, PHAT quarterly net profit is -$29.97 million, with the most recent change of +$45.84 million (+60.46%) on September 30, 2025.
  • Over the past year, PHAT quarterly net income has increased by +$55.60 million (+64.98%).
  • PHAT quarterly net income is now -10235.52% below its all-time high of -$290.00 thousand, reached on September 30, 2018.

Performance

PHAT Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

TTM Net Income:

-$274.55M+$55.60M(+16.84%)
September 30, 2025

Summary

  • As of today, PHAT TTM net profit is -$274.55 million, with the most recent change of +$55.60 million (+16.84%) on September 30, 2025.
  • Over the past year, PHAT TTM net income has increased by +$64.89 million (+19.12%).
  • PHAT TTM net income is now -94572.41% below its all-time high of -$290.00 thousand, reached on September 30, 2018.

Performance

PHAT TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PHAT Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-65.8%+65.0%+19.1%
3Y3 Years-132.4%+41.3%-53.8%
5Y5 Years-31.0%+12.1%-58.4%

PHAT Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-132.4%at lowat high+68.2%-55.0%+20.6%
5Y5-Year-159.0%at lowat high+68.2%-112.7%+20.6%
All-TimeAll-Time>-9999.0%at low>-9999.0%+69.4%>-9999.0%+20.6%

PHAT Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$29.97M(+60.5%)
-$274.55M(+16.8%)
Jun 2025
-
-$75.81M(+19.6%)
-$330.15M(+4.5%)
Mar 2025
-
-$94.32M(-26.7%)
-$345.79M(-3.4%)
Dec 2024
-$334.33M(-65.8%)
-$74.45M(+13.0%)
-$334.33M(+1.5%)
Sep 2024
-
-$85.58M(+6.4%)
-$339.44M(-14.2%)
Jun 2024
-
-$91.45M(-10.4%)
-$297.11M(-20.5%)
Mar 2024
-
-$82.85M(-4.1%)
-$246.63M(-22.3%)
Dec 2023
-$201.59M(-2.0%)
-$79.57M(-84.0%)
-$201.59M(-13.8%)
Sep 2023
-
-$43.24M(-5.6%)
-$177.07M(+4.2%)
Jun 2023
-
-$40.97M(-8.3%)
-$184.92M(+5.1%)
Mar 2023
-
-$37.81M(+31.3%)
-$194.87M(+1.4%)
Dec 2022
-$197.72M
-$55.05M(-7.7%)
-$197.72M(-10.8%)
Sep 2022
-
-$51.09M(-0.3%)
-$178.50M(-8.8%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$50.92M(-25.2%)
-$164.07M(-9.6%)
Mar 2022
-
-$40.66M(-13.5%)
-$149.71M(-4.0%)
Dec 2021
-$143.88M(-11.5%)
-$35.83M(+2.3%)
-$143.88M(+11.1%)
Sep 2021
-
-$36.66M(-0.3%)
-$161.78M(-1.6%)
Jun 2021
-
-$36.55M(-4.9%)
-$159.22M(-10.7%)
Mar 2021
-
-$34.84M(+35.1%)
-$143.77M(-11.4%)
Dec 2020
-$129.07M(+49.4%)
-$53.72M(-57.5%)
-$129.07M(+25.5%)
Sep 2020
-
-$34.10M(-61.6%)
-$173.35M(+16.4%)
Jun 2020
-
-$21.10M(-4.8%)
-$207.36M(-11.3%)
Mar 2020
-
-$20.14M(+79.4%)
-$186.26M(-12.1%)
Dec 2019
-$255.13M(>-9900.0%)
-$98.01M(-43.9%)
-$166.12M(-143.9%)
Sep 2019
-
-$68.11M(>-9900.0%)
-$68.11M(>-9900.0%)
Dec 2018
-$1.29M
-
-
Sep 2018
-
-$290.00K
-$290.00K

FAQ

  • What is Phathom Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Phathom Pharmaceuticals, Inc. annual net profit?

The current annual net income of PHAT is -$334.33M

What is the all-time high annual net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high annual net profit is -$1.29M

What is Phathom Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, PHAT annual net profit has changed by -$132.73M (-65.84%)

What is Phathom Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of PHAT is -$29.97M

What is the all-time high quarterly net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high quarterly net profit is -$290.00K

What is Phathom Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, PHAT quarterly net profit has changed by +$55.60M (+64.98%)

What is Phathom Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of PHAT is -$274.55M

What is the all-time high TTM net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high TTM net profit is -$290.00K

What is Phathom Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, PHAT TTM net profit has changed by +$64.89M (+19.12%)
On this page